Key Technicals - flag/ascending triangle, entry on breakout.
Key Fundamentals - the Australian Government’s Medical Research Future Fund (MRFF) through the
Biomedical Translation Bridge (BTB) program is supporting development and clinical evaluation of
DMX-200 as a new treatment for respiratory complications as a result of COVID-19 in global clinical
study with a potential fast track pathway to clinical practice.
Key Fundamentals - the Australian Government’s Medical Research Future Fund (MRFF) through the
Biomedical Translation Bridge (BTB) program is supporting development and clinical evaluation of
DMX-200 as a new treatment for respiratory complications as a result of COVID-19 in global clinical
study with a potential fast track pathway to clinical practice.
Comment:
DXB has been in a trading halt this week due to price sensitive announcement.